NIAID Clinical Trial Implementation Grant (U01) from the Department of Health and Human Services

Opportunity ID: 43505

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-05-113
Funding Opportunity Title: NIAID Clinical Trial Implementation (U01) Cooperative Agreement
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 02, 2008
Last Updated Date: Mar 13, 2009
Original Closing Date for Applications: May 07, 2009
Current Closing Date for Applications: Jan 07, 2010
Archive Date: Feb 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
State governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Non-domestic (non-U.S.) Entities (Foreign Organizations).

Additional Information

Agency Name: National Institutes of Health
Description: Beginning with the May 1, 2006 receipt date for AIDS applications and the June 1, 2006 receipt date for non-AIDS applications, NIAID will accept, peer review, and consider for funding applications for implementation of investigator-initiated clinical trials only from NIAID Clinical Trial Planning (R34) grant awardees (See PAR-05-112 for information on NIAID Clinical Trial Planning Grants). Each clinical trial implementation application will use the PHS 398 grant application with special instructions and will include a copy of the Institutional Review Board (IRB) approved study protocol, investigators brochure or equivalent, and a manual of operations or equivalent. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements. In order not to delay the initiation of the clinical trial, the peer review and award of the clinical trial implementation grant will be completed within four months of the receipt of the application.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-05-113.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Modified Archive Date based on new Expiration Date, per NOT-AI-09-020. Mar 13, 2009
Mar 13, 2009

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-05-113
Funding Opportunity Title: NIAID Clinical Trial Implementation (U01) Cooperative Agreement
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 02, 2008
Last Updated Date: Mar 13, 2009
Original Closing Date for Applications: May 07, 2009
Current Closing Date for Applications: Jan 07, 2010
Archive Date: Feb 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
State governments
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Non-domestic (non-U.S.) Entities (Foreign Organizations).

Additional Information

Agency Name: National Institutes of Health
Description: Beginning with the May 1, 2006 receipt date for AIDS applications and the June 1, 2006 receipt date for non-AIDS applications, NIAID will accept, peer review, and consider for funding applications for implementation of investigator-initiated clinical trials only from NIAID Clinical Trial Planning (R34) grant awardees (See PAR-05-112 for information on NIAID Clinical Trial Planning Grants). Each clinical trial implementation application will use the PHS 398 grant application with special instructions and will include a copy of the Institutional Review Board (IRB) approved study protocol, investigators brochure or equivalent, and a manual of operations or equivalent. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements. In order not to delay the initiation of the clinical trial, the peer review and award of the clinical trial implementation grant will be completed within four months of the receipt of the application.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-05-113.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-05-113
Funding Opportunity Title: NIAID Clinical Trial Implementation (U01) Cooperative Agreement
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 13, 2009
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: May 07, 2009
Archive Date: Jun 07, 2009
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Non-domestic (non-U.S.) Entities (Foreign Organizations).

Additional Information

Agency Name: National Institutes of Health
Description: Beginning with the May 1, 2006 receipt date for AIDS applications and the June 1, 2006 receipt date for non-AIDS applications, NIAID will accept, peer review, and consider for funding applications for implementation of investigator-initiated clinical trials only from NIAID Clinical Trial Planning (R34) grant awardees (See PAR-05-112 for information on NIAID Clinical Trial Planning Grants). Each clinical trial implementation application will use the PHS 398 grant application with special instructions and will include a copy of the Institutional Review Board (IRB) approved study protocol, investigators brochure or equivalent, and a manual of operations or equivalent. These documents must meet all National Institutes of Health (NIH), Food and Drug Administration (FDA), and Office of Human Research Protections (OHRP) requirements. All awards will be made as cooperative agreements. In order not to delay the initiation of the clinical trial, the peer review and award of the clinical trial implementation grant will be completed within four months of the receipt of the application.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-05-113.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *